WVE Wave Life Sciences Ltd
- Stocks
- Healthcare
- NASDAQ: WVE
Price (delayed)
$8.45
Market cap
$1.34B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.8
Enterprise value
$1.16B
Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using
Highlights
Wave Life Sciences's debt has decreased by 25% YoY and by 8% QoQ
The quick ratio has soared by 167% YoY but it fell by 14% QoQ
The company's net income has shrunk by 77% YoY and by 16% QoQ
Wave Life Sciences's EPS has decreased by 40% YoY and by 8% from the previous quarter
Key stats
What are the main financial stats of WVE
Market
Valuations
Earnings
Shares outstanding
159.14M
Market cap
$1.34B
Enterprise value
$1.16B
Price to earnings (P/E)
N/A
Price to book (P/B)
9.35
Price to sales (P/S)
14.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.33
Revenue
$93.95M
Gross profit
$93.95M
Operating income
-$143.51M
Net income
-$129.87M
EBIT
-$129.87M
EBITDA
-$121.2M
Free cash flow
-$200.12M
Per share
Balance sheet
Liquidity
EPS
-$0.8
EPS diluted
-$0.8
Free cash flow per share
-$1.22
Book value per share
$0.9
Revenue per share
$0.57
TBVPS
$1.54
Total assets
$252.36M
Total liabilities
$105.22M
Debt
$21.71M
Equity
$139.27M
Working capital
$136.15M
Debt to equity
0.16
Current ratio
2.56
Quick ratio
2.4
Net debt/EBITDA
1.54
Margins
Efficiency
Dividend
EBITDA margin
-129%
Gross margin
100%
Net margin
-138.2%
Operating margin
-152.8%
Return on assets
-41.5%
Return on equity
-78.4%
Return on invested capital
N/A
Return on capital employed
-78.7%
Return on sales
-138.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
WVE stock price
How has the Wave Life Sciences stock price performed over time
Intraday
4.26%
1 week
-4.41%
1 month
9.74%
1 year
57.36%
YTD
-31.69%
QTD
30%
Financial performance
How have Wave Life Sciences's revenue and profit performed over time
Revenue
$93.95M
Gross profit
$93.95M
Operating income
-$143.51M
Net income
-$129.87M
Gross margin
100%
Net margin
-138.2%
Wave Life Sciences's net margin has shrunk by 108% YoY and by 29% QoQ
The operating margin has plunged by 102% YoY and by 28% from the previous quarter
The company's net income has shrunk by 77% YoY and by 16% QoQ
The operating income has plunged by 71% YoY and by 14% from the previous quarter
Price vs fundamentals
How does WVE's price correlate with its fundamentals
Growth
What is Wave Life Sciences's growth rate over time
Valuation
What is Wave Life Sciences stock price valuation
P/E
N/A
P/B
9.35
P/S
14.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.33
Wave Life Sciences's EPS has decreased by 40% YoY and by 8% from the previous quarter
The equity has contracted by 19% from the previous quarter
The stock's price to book (P/B) is 16% more than its last 4 quarters average of 7.7
The P/S is 38% below the 5-year quarterly average of 22.7 and 6% below the last 4 quarters average of 15.0
Wave Life Sciences's revenue has decreased by 15% YoY and by 10% QoQ
Efficiency
How efficient is Wave Life Sciences business performance
Wave Life Sciences's ROS has plunged by 106% YoY and by 29% from the previous quarter
Wave Life Sciences's return on equity has surged by 94% YoY and by 9% QoQ
WVE's return on assets is down by 29% year-on-year and by 12% since the previous quarter
Dividends
What is WVE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for WVE.
Financial health
How did Wave Life Sciences financials performed over time
The total assets is 140% greater than the total liabilities
The quick ratio has soared by 167% YoY but it fell by 14% QoQ
WVE's current ratio has soared by 159% year-on-year but it is down by 13% since the previous quarter
Wave Life Sciences's debt is 84% lower than its equity
Wave Life Sciences's debt to equity has soared by 102% YoY and by 14% from the previous quarter
Wave Life Sciences's debt has decreased by 25% YoY and by 8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.